{"ticker": {"uuid": "59b37edd-e336-4665-992e-68d8ca6142c3", "symbol": "IMM", "name": "ImmuPharma plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "ImmuPharma advances P140 partnering strategy following \u00a36.5m raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPT2dxM2VvNU5WZW9ZbFNsRWhFY0swalZEMExHZXJLWkVRUkNCMUF6SlF4ZVp6T0dmMGFiRE04TXhuZHJXMS1KU09XbndwaWtRcGR1RzFmVEp0cC10aVNTUWJudFU2NTBNYllBUmp0dlVlWFFkTlBlSjhvWTBOWENsNm1xUE5fUUlhYjk5WEJUMjltVEM3S3pCMg?oc=5", "source_name": "Share Talk", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma launches retail share offer to raise \u00a31.5 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTlBROEZleTVsOC1BaTFGakhoRlgzalJKcmoyQXlKX3pDQldmaFRpWGxnM1NfWWJjR0JCWktwUENjZFpNN2FPZEsyOXdkZGNXdmdIZGh4MTZhbEtDUExjN2tneUxBZkJZM0xZWGx6ODZZOFpFcF81V3lGRmtBZDhoY2FYU2VMNUZJSE52MlJ0emhPRDRCMnNxQ3dsTTRYVmM5SUxIY1lFc3o4bF9nYVhWazdnX1pFUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Institutional investors are ImmuPharma plc's (LON:IMM) biggest bettors and were rewarded after last week's UK\u00a348m market cap gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 80% ownership in ImmuPharma plc (LON:IMM), institutional investors have a lot riding on the business", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQcEszbHJuYUZXaXZTakhUUU9TRmxRd2Q1dFd5bV8xTTNUNnkwMDVsVlcyaGFkbHg4QnlpTlc3Y0dVeWpZZElfbVVlMVBHb2FSd1BEVURIR1NoZW13TnVMMGJwZ2ZZUmpRWUlDbGF2MkM3X2VTRW5NNy1XYWdWWGgwa3FTOA?oc=5", "source_name": "Market source", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma shoots up 300% after it inks US licensing deal for flagship drug Lupuzor", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNdjhJa3AtM2Z0dVNFZzMtRjJRRTYtakY2UTBBeVNqdDVlckl6SGNBQl9OTkxWWU5fRXJpZHd3aTdJTjF1RDF2RllKSlV3cjdqU0xkbF9yM1lvM0JIbVA5YWVubHNoREYtMjdnX3RjRUpUNTZWN1NfNDFhYlktSkxRWk9FVmN1ZnUwOGx1b2ZKOVhqQzI3bWZ6YjF4RkJfejF0Z1ZJZzRDeklwUS1RdEM3cVJmdF9kT2NPWHBxdURWc0tndzl2SmZrckJvUTZlcjdNRV9NUjRLazNLQnoydVVONXRNbV9saXRU?oc=5", "source_name": "Proactive Investors", "published_at": "2019-11-28T08:00:00+00:00", "published_display": "28 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMM Stock Price and Chart \u2014 LSE:IMM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE55ZDJWaC05MmltR0Yta2xuMWJrRHJSR3ZCbWQwWnhTRm82WFAtQlJONG00TEhzZURWTnhqWFphODU2SllWdFVQckxGYzdMTlRYUkV6dmxHdw?oc=5", "source_name": "TradingView", "published_at": "2017-08-04T15:39:51+00:00", "published_display": "04 Aug 2017 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma (IMM) Share Price, Stock Value, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBVRWcwc25GbHl4NkVSYzRlalJac2RJU1NmU3NrSXdFRU9wRVE4YkZNX0RfRktlcmNncF9XdDNoWVFuaHZkVmRrOGRDMmFWNmphT09HMw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-16T10:14:34+00:00", "published_display": "16 Aug 2016 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma PLC Share Price - IMM, RNS News, Articles, Quotes, & Charts (LON:IMM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE5vZHBrWTVVclg4YnJDa1JSN0I5MFZuVHZtMmxqZV9ZX2ozbHdLaV9ldFZrWWdlTkVLTEVpTE8yX1RYY0JUN2c3QVZBam56cURHUnRuNkNuWE85VjJEakg3Vk9QREUyNnhxU0NR?oc=5", "source_name": "Proactive Investors", "published_at": "2016-03-20T10:52:43+00:00", "published_display": "20 Mar 2016 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ImmuPharma advances P140 partnering strategy following \u00a36.5m raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPT2dxM2VvNU5WZW9ZbFNsRWhFY0swalZEMExHZXJLWkVRUkNCMUF6SlF4ZVp6T0dmMGFiRE04TXhuZHJXMS1KU09XbndwaWtRcGR1RzFmVEp0cC10aVNTUWJudFU2NTBNYllBUmp0dlVlWFFkTlBlSjhvWTBOWENsNm1xUE5fUUlhYjk5WEJUMjltVEM3S3pCMg?oc=5", "source_name": "Share Talk", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma launches retail share offer to raise \u00a31.5 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTlBROEZleTVsOC1BaTFGakhoRlgzalJKcmoyQXlKX3pDQldmaFRpWGxnM1NfWWJjR0JCWktwUENjZFpNN2FPZEsyOXdkZGNXdmdIZGh4MTZhbEtDUExjN2tneUxBZkJZM0xZWGx6ODZZOFpFcF81V3lGRmtBZDhoY2FYU2VMNUZJSE52MlJ0emhPRDRCMnNxQ3dsTTRYVmM5SUxIY1lFc3o4bF9nYVhWazdnX1pFUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Institutional investors are ImmuPharma plc's (LON:IMM) biggest bettors and were rewarded after last week's UK\u00a348m market cap gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 80% ownership in ImmuPharma plc (LON:IMM), institutional investors have a lot riding on the business", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQcEszbHJuYUZXaXZTakhUUU9TRmxRd2Q1dFd5bV8xTTNUNnkwMDVsVlcyaGFkbHg4QnlpTlc3Y0dVeWpZZElfbVVlMVBHb2FSd1BEVURIR1NoZW13TnVMMGJwZ2ZZUmpRWUlDbGF2MkM3X2VTRW5NNy1XYWdWWGgwa3FTOA?oc=5", "source_name": "Market source", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma shoots up 300% after it inks US licensing deal for flagship drug Lupuzor", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNdjhJa3AtM2Z0dVNFZzMtRjJRRTYtakY2UTBBeVNqdDVlckl6SGNBQl9OTkxWWU5fRXJpZHd3aTdJTjF1RDF2RllKSlV3cjdqU0xkbF9yM1lvM0JIbVA5YWVubHNoREYtMjdnX3RjRUpUNTZWN1NfNDFhYlktSkxRWk9FVmN1ZnUwOGx1b2ZKOVhqQzI3bWZ6YjF4RkJfejF0Z1ZJZzRDeklwUS1RdEM3cVJmdF9kT2NPWHBxdURWc0tndzl2SmZrckJvUTZlcjdNRV9NUjRLazNLQnoydVVONXRNbV9saXRU?oc=5", "source_name": "Proactive Investors", "published_at": "2019-11-28T08:00:00+00:00", "published_display": "28 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMM Stock Price and Chart \u2014 LSE:IMM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE55ZDJWaC05MmltR0Yta2xuMWJrRHJSR3ZCbWQwWnhTRm82WFAtQlJONG00TEhzZURWTnhqWFphODU2SllWdFVQckxGYzdMTlRYUkV6dmxHdw?oc=5", "source_name": "TradingView", "published_at": "2017-08-04T15:39:51+00:00", "published_display": "04 Aug 2017 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma (IMM) Share Price, Stock Value, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTFBVRWcwc25GbHl4NkVSYzRlalJac2RJU1NmU3NrSXdFRU9wRVE4YkZNX0RfRktlcmNncF9XdDNoWVFuaHZkVmRrOGRDMmFWNmphT09HMw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-16T10:14:34+00:00", "published_display": "16 Aug 2016 10:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ImmuPharma PLC Share Price - IMM, RNS News, Articles, Quotes, & Charts (LON:IMM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE5vZHBrWTVVclg4YnJDa1JSN0I5MFZuVHZtMmxqZV9ZX2ozbHdLaV9ldFZrWWdlTkVLTEVpTE8yX1RYY0JUN2c3QVZBam56cURHUnRuNkNuWE85VjJEakg3Vk9QREUyNnhxU0NR?oc=5", "source_name": "Proactive Investors", "published_at": "2016-03-20T10:52:43+00:00", "published_display": "20 Mar 2016 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 8, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 5, "score": 56, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.04, "latest_week": "2026-07-10", "one_week_move": 16.4, "four_week_move": -15.9, "twelve_week_move": -15.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.204131, "market_dynamics_buy_signal": false, "relative_strength": -39.68597, "fair_value_gap": 14.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.297, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+16.4% over one week, -15.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Proactive Investors", "count": 2}, {"label": "Share Talk", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Market source", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+16.4% over one week, -15.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "ImmuPharma advances P140 partnering strategy following \u00a36.5m raise"}], "updated_at": "2026-07-17T13:49:02.182620+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}